| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.08 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |